Article

Ultraviolet A-1 Phototherapy: Alternative Alopecia Areata Treatment

Author(s):

Phototherapy with ultraviolet A-1 (UVA-1) has been considered a promising treatment option for patients afflicted with alopecia areata.

Phototherapy with ultraviolet A-1 (UVA-1) has been considered a promising treatment option for patients afflicted with alopecia areata.

A research letter recently published in the International Journal of Dermatology, followed Maira E. Herz-Ruelas, MD, University Hospital, Monterrey, Mexico, and her colleagues’ study in which they treated four patients with refractory alopecia areata with UVA-1 phototherapy.

Before and after 75 sessions, the team withdrew two separate 4 mm punch scalp biopsies from alopecic plaque. Following the 75 sessions, study results indicated that all four patients showed a prominent reduction of inflammatory infiltrate, a reduction in telogen hairs, and miniaturization of hair follicles with simultaneous increase in anagen hairs.

Using the severity of alopecia tool (SALT), three patients received a score of S0 and the patient who demonstrated the most severe alopecia had a score of S1 with hair regrowth.

Furthermore, the levels of improvement were maintained even after six months post treatment.

Herz-Ruelas and colleagues concluded, “To the best of our knowledge, this is an initial report of hair regrowth with this phototherapy. We feel that UVA-1 could be included as a therapeutic alternative for patients unresponsive to previous topical or systemic pharmacological treatments.”

Related Videos
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD
2 Additional Clinical Pearls for Dermatologists, with Eingun James Song, MD
2 Helpful Clinical Tips for Dermatologists, with Eingun James Song, MD
What Are Some Other Methods To Manage Skin Cancer Outside of Biopsies?
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
© 2024 MJH Life Sciences

All rights reserved.